Seeking Alpha

Henry McCusker  

Editor and Publisher ... Henry enters his thirteen (13) year at RegMed Investors which aggregates, curates and creates bottom-line content of regenerative medicine - stem, gene and cell therapy news providing a "vetted" selection of relevant and high-impact synthesis.

He was VP - Strategic Planning and Communication at Curis (2001-2002), HQCM focusing on healthcare investments (NYSE:HQH/HQL) from (1985-2001)and founded LifeScience Economics, a healthcare research and analytics firm with offices in Boston, MA and Palo Alto, CA. Past experiences include Thermo Scientific, SWEC following 5 years at the FBI. A former military officer, Henry has been an adjunct professor at Boston University and Golden ...More
  • Description: Writer. Trading frequency: Weekly
  • Interests: Stocks - long, Stocks - short
Scimitar Equity-Regenerative Medicine Investors Scimitar Equity's mission is to provide investors with real-time actionable intelligence to define the short, near and long term catalysts.
Scimitar Equity Blog I started this commentary to update news flow and insightful opinions. Wall Street has dramatically slashed its ranks of analysts providing research but, scientific platforms and industry sectors need to be better researched for conviction ideas.
Currently, you have no book details. Click edit to add book details.
ImmunoCellular (OTC BB: IMUC) files to Sell $13.8M of Units via Cowen Nov 30, 2011